Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01986738 · ClinicalTrials.gov registry record

A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer

A clinical trial, sponsored by University of Michigan Rogel Cancer Center.

Completed
Registry status
9
Enrollment target

NCT01986738 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01986738 has completed, sponsored by University of Michigan Rogel Cancer Center.

COMPLETED
Registry status
9 participants
Enrollment target

Study Summary

This is a study to assess the motion of pancreatic tumors during radiation therapy using Computed Tomography (CT) Scans and an Active Breathing Control (ABC) Device.

Interventions

  • RADIATION Standard Radiation Therapy
  • DEVICE Active Breathing Control Device (ABC)
  • DEVICE Computed Tomography Scan (CT)

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2012-01
Est. Completion 2013-09

What the Registry Record Tells You About NCT01986738

The ClinicalTrials.gov registry entry for NCT01986738 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Standard Radiation Therapy is the first listed.

NCT01986738 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01986738 about?

NCT01986738 is a clinical study titled "A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer". This is a study to assess the motion of pancreatic tumors during radiation therapy using Computed Tomography (CT) Scans and an Active Breathing Control (ABC) Device.

What is the current status of trial NCT01986738?

This trial is currently completed. The enrollment target is 9 participants. The study started on 2012-01. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01986738?

The interventions under investigation include: Standard Radiation Therapy (RADIATION), Active Breathing Control Device (ABC) (DEVICE), Computed Tomography Scan (CT) (DEVICE).

Who is sponsoring clinical trial NCT01986738?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.